EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE

被引：9
|
作者：
Yazici, Y. [1 ]
McAlindon, T. E. [2 ]
Gibofsky, A. [3 ,4 ]
Lane, N. E. [5 ]
Latterman, C. [6 ]
Skrepnik, N. [7 ]
Swearingen, C. J. [1 ]
DiFrancesco, A. [1 ]
Tambiah, J. R. [1 ]
Hochberg, M. C. [8 ]
机构：
[1] Samumed, San Diego, CA USA
[2] Tufts Med Ctr, Boston, MA 02111 USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[5] Univ Calif Davis, Med Ctr, Davis, CA USA
[6] Harvard Univ, Brigham & Womens Hosp, Cambridge, MA 02138 USA
[7] Tucson Orthoped Inst, Tucson, AZ USA
[8] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
OSTEOARTHRITIS AND CARTILAGE | 2019年 / 27卷
关键词：
D O I：
10.1016/j.joca.2019.02.566
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
728
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [31] ANTI-INFLAMMATORY PROPERTIES OF SM04690, A SMALL MOLECULE INHIBITOR OF THE WNT PATHWAY AS A POTENTIAL TREATMENT FOR KNEE OSTEOARTHRITIS
    Deshmukh, V.
    Barroga, C.
    Ibanez, M.
    Seo, T.
    Kc, S.
    Dellamary, L.
    Stewart, J.
    Yazici, Y.
    OSTEOARTHRITIS AND CARTILAGE, 2017, 25 : S310 - S311
  • [32] TREATMENT OF KNEE OSTEOARTHRITIS WITH SM04690 IMPROVED WOMAC A1 'PAIN ON WALKING' RESULTS FROM A 52 WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR
    Kennedy, S.
    Ghandehari, H.
    Swearingen, C.
    Tambiah, J.
    Hochberg, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 81 - 82
  • [33] Lorecivivint (SM04690), an Intra-articular, Small-Molecule CLK/DYRK Inhibitor That Modulates the Wnt Pathway, as a Potential Treatment for Meniscal Injuries
    Seo, Timothy
    Deshmukh, Vishal
    Yazici, Yusuf
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3087 - 3088
  • [34] LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL-MOLECULE CLK/DYRK INHIBITOR THAT MODULATES THE WNT PATHWAY, AS A POTENTIAL TREATMENT FOR MENISCAL INJURIES
    Seo, T.
    Deshmukh, V.
    Yazici, Y.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S297 - S297
  • [35] A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee
    Deshmukh, V.
    Hu, H.
    Barroga, C.
    Bossard, C.
    Kc, S.
    Dellamary, L.
    Stewart, J.
    Chiu, K.
    Ibanez, M.
    Pedraza, M.
    Seo, T.
    Do, L.
    Cho, S.
    Cahiwat, J.
    Tam, B.
    Tambiah, J. R. S.
    Hood, J.
    Lane, N. E.
    Yazici, Y.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 (01) : 18 - 27
  • [36] Treatment of Knee Osteoarthritis with SM04690 Improved WOMAC A1 "Pain on Walking" - Results from a 52-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor
    Tambiah, Jeyanesh
    Kennedy, Sarah
    Ghandehari, Heli
    Swearingen, Christopher
    Hochberg, Marc C.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [37] ANTI-INFLAMMATORY PROPERTIES OF SM04690, A SMALL MOLECULE INHIBITOR OF THE WNT PATHWAY AS A POTENTIAL TREATMENT FOR KNEE OSTEOARTHRITIS
    Deshmukh, V.
    Barroga, C.
    Ibanez, M.
    Seo, T.
    Kc, S.
    Yazici, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 984 - 984
  • [38] SAFETY, CLINICAL AND IMAGING OUTCOMES OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE: EXPLORATORY ANALYSIS OF RESULTS FROM A 24 WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY
    Yazici, Y.
    McAlindon, T. E.
    Fleischmann, R. M.
    Gibofsky, A.
    Lane, N. E.
    Kivitz, A. J.
    Majumdar, S.
    Strand, V.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J.
    Hood, J.
    Hochberg, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 826 - 826
  • [39] OMERACT-OARSI 'STRICT RESPONDERS' ANALYSIS FROM RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Y.
    Tambiah, J.
    Swearingen, C. J.
    DiFrancesco, A.
    Strand, V.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S187 - S187
  • [40] A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study
    Yazici, Y.
    McAlindon, T. E.
    Fleischmann, R.
    Gibofsky, A.
    Lane, N. E.
    Kivitz, A. J.
    Skrepnik, N.
    Armas, E.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R. S.
    Hood, J.
    Hochberg, M. C.
    OSTEOARTHRITIS AND CARTILAGE, 2017, 25 (10) : 1598 - 1606
12345